Navigation Links
ALIMTA First Chemotherapy Approved in Europe as Continuation Maintenance Therapy for Most Common Form of Lung Cancer
Date:10/28/2011

ely new concept in lung cancer treatment, in which patients start maintenance therapy immediately following their first-line treatments to try to maintain disease control. No other chemotherapy is currently approved in the "continuation maintenance" setting, in which one of the same medicines used in first-line treatment is continued as maintenance therapy. Previously approved maintenance therapies in lung cancer use different medicines in the first-line and maintenance phases of treatment.

About NSCLC

Globally, lung cancer is the most common form of cancer and the biggest killer, causing 1.3 million cancer deaths annually.(2) About 85 – 90 percent of all lung cancers are NSCLC.(3) The liver, bones and brain are potential targets if the cancerous cells enter the bloodstream.

NSCLC comprises a group of histologies or tumor types differentiated by cellular structure. Nonsquamous histology includes adenocarcinoma,(4) as well as histologies classified as 'other.'

About Lilly Oncology, a Division of Eli Lilly and Company

For more than four decades, Lilly Oncology, a division of Eli Lilly and Company, has been dedicated to delivering innovative solutions that improve the care of people living with cancer.  Because no two cancer patients are alike, Lilly Oncology is committed to developing novel treatment approaches. To learn more about Lilly's commitment to cancer, please visit www.LillyOncology.com.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs.

P-LLY


'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
2. OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer
3. U.S. District Court Rules from Bench in Lillys Favor, Confirms Validity of Alimta Patent
4. Lung Cancer Study Reveals Similar Outcomes for African-American and Caucasian Patients Treated With Alimta®
5. ALIMTA Receives Positive Opinion From CHMP as Continuation Maintenance Therapy for Deadly Form of Lung Cancer
6. ALIMTA Helped Keep Most Common Form of Lung Cancer at Bay In Elderly Patients
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , August 20, 2014 Phase ... in the US  KalVista Pharmaceuticals ("KalVista"), an ... (DME), today announces that it has begun a Phase ... kallikrein inhibitor, KVD001, for the treatment of DME. The ... the Beetham Eye Institute, Joslin Diabetes Center; Harvard Medical ...
(Date:8/19/2014)... , Aug. 19, 2014   Lincor ... its patient experience technology to New ... the five-year agreement, CarePoint Health will deploy Lincor,s ... Medical Center, Christ Hospital and Hoboken University Medical ... a range of software solutions to help hospitals ...
(Date:8/19/2014)... -- The Alabama Supreme Court, in a 6-3 decision on August ... mislead doctors into believing that prescription medicines the companies market ... Wyeth, and the decision came after the Supreme Court ruled ... Heninger Garrison Davis attorneys Lew Garrison and ... Danny Weeks . The decision won a clear ...
Breaking Medicine Technology:KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4Lincor Announces Agreement With CarePoint Health For State-Of-The-Art Patient Engagement Technology 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4
... 13 Octapharma USA ... therapy development specifically for von Willebrand Disease (VWD), is now ... Food and Drug Administration (FDA) has approved wilate® ... in patients with severe VWD as well as in patients ...
... May 13 Stereotaxis, (Nasdaq: STXS ... with complex arrhythmias such as atrial fibrillation, ventricular tachycardia, ... the scientific program of the 31st Annual Heart Rhythm ... presentations and eight posters will underscore the broad clinical ...
Cached Medicine Technology:Octapharma USA Announces Availability and Distributors for wilate®, the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces Availability and Distributors for wilate®, the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces Availability and Distributors for wilate®, the First Replacement Therapy Developed Specifically for von Willebrand Disease 4New Data Demonstrate Safety, Efficacy of Stereotaxis for Patients with AFIB, VT and Congenital Defects 2New Data Demonstrate Safety, Efficacy of Stereotaxis for Patients with AFIB, VT and Congenital Defects 3New Data Demonstrate Safety, Efficacy of Stereotaxis for Patients with AFIB, VT and Congenital Defects 4New Data Demonstrate Safety, Efficacy of Stereotaxis for Patients with AFIB, VT and Congenital Defects 5New Data Demonstrate Safety, Efficacy of Stereotaxis for Patients with AFIB, VT and Congenital Defects 6
(Date:8/20/2014)... No matter how “lonely” a person may be, he ... friends to be always there for them. However, it is ... making new friends during adulthood : not only is ... of one’s family to a near-slavish devotion to career-building, the ... just is not the same as it was when one ...
(Date:8/20/2014)... 20, 2014 Building on growing ... successfully predicted stage iii and iv pressure ulcers ... situations, approached 90%. A company spokesperson commented that ... commercial or academic settings. The resulting capabilities can ... of hospital-acquired conditions to help providers avoid financial ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 “Have you recently ... auto accident and personal injury lawyer serving the greater Seattle ... incident? If so, then keep reading . , In ... individuals injured in an auto accident can use to see ... explains that a personal injury insurance claim will allow an ...
(Date:8/20/2014)... Ticketability.com has Theresa Caputo ... prices. The well-known medium has been thrilling many with ... in 19 cities, with tickets becoming available August 15. ... visit are Albany, Baltimore, Trenton, Erie, Buffalo, Philadelphia, Charlotte, ... and San Diego. The medium’s fans can obtain Theresa ...
(Date:8/20/2014)... Wisconsin (PRWEB) August 20, 2014 BuyCheapTicketsToEvents.com ... and a wide selection of tickets to many events. Cheap ... that will begin in September. , Hockey fans are enthusiastic ... to obtain tickets for games. Now is the time to ... to begin in mere months. There will be a great ...
Breaking Medicine News(10 mins):Health News:‘How to Make Friends as an Adult by Just Being Yourself: Becoming a “People Person” In Three Steps or Less’ Gives Tips for Making Friends During Adulthood - Vinamy 2Health News:Jvion Achieves Benchmark Accuracy in Pressure Ulcer Prediction 2Health News:Five Questions to Determine Who Qualifies for a Personal Injury Claim Recently Released by The Jones Firm in Recent Article 2Health News:Theresa Caputo Tour Tickets for Sale at Ticketability.com Cause a Buying Frenzy Among Customers Over Their Offering of Deeply Discounted Seats 2Health News:2014 NHL Preseason Tickets Are Among Top Selling Seats at Trusted Provider BuyCheapTicketsToEvents.com 2
... pediatric research institution , ... Washington, DC (Vocus) November ... Research Institute , dedicated new research facilities today, increasing the space ... than 100,000 square feet. , , , , ,Elected officials and ...
... MedNotes offers personalized medication profiles, drug interaction and warning ... , NEW YORK, Nov. 24 ... medication and related health issues, today announced the launch ... way consumers can monitor and manage their own medications, ...
... For over a decade Ochsner Health System,has enjoyed a ... improved patient care, cost savings and increased revenues for,Ochsner,s ... New Orleans have,seen more than their share of tragedy. ... left the greater New Orleans hospital infrastructure,badly damaged. ...
... With the bWell-informed Health Plan Forecaster, Medicare shoppers can ... , NEW YORK, Nov. ... first day of the holiday shopping rush. For seniors ... options, there,s no better time to "shop" for coverage ...
... Nov. 24 In preparation for its January 1,2009 ... Francisco,s highly regarded Institute on Aging (IOA). , ... nonprofit, membership-based, "aging-in-place",program designed to help older adults and ... apartments, and neighborhoods as long as they wish or ...
... 75th Annual Stockholders Meeting of Florida’s Natural Growers ... on Monday, the 17th of November. The theme ... Value,” was appropriate since the Cooperative reported one ... despite an extremely challenging economic environment. In fact, ...
Cached Medicine News:Health News:Children's National Dedicates New Research Facility 2Health News:Children's National Dedicates New Research Facility 3Health News:Drugs.com Unveils the Next Generation Medication Safety Tool to Help Consumers Avoid Dangerous Drug Interactions 2Health News:Drugs.com Unveils the Next Generation Medication Safety Tool to Help Consumers Avoid Dangerous Drug Interactions 3Health News:Drugs.com Unveils the Next Generation Medication Safety Tool to Help Consumers Avoid Dangerous Drug Interactions 4Health News:Drugs.com Unveils the Next Generation Medication Safety Tool to Help Consumers Avoid Dangerous Drug Interactions 5Health News:Ochsner Health System, Surgical Information Systems Partner to Rebuild New Orleans Healthcare Infrastructure 2Health News:Ochsner Health System, Surgical Information Systems Partner to Rebuild New Orleans Healthcare Infrastructure 3Health News:bWell-informed(TM) Adds Medicare Plan Tools for 2008 Open Enrollment Season 2Health News:Institute on Aging Collaborates With New Program San Francisco Village 2Health News: Florida's Natural Celebrates 75 Years with Record Performance 2Health News: Florida's Natural Celebrates 75 Years with Record Performance 3
... Cruise Control is ... STAAR as a filter ... and aspiration tubing that ... the safety and efficiency ...
... The robust, compact Sleepscan Traveler provides the ... can acquire PSG data in the home, ... laboratory. Traveler sleep studies utilize the same ... in-lab studies. Sleepscan Traveler studies take full ...
... Pioneer in Digital EEG ,The company ... system presents the latest addition to ... VISION. This innovative system incorporates the ... and information management to offer you ...
"Ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Complies with international standards of electrophysiology....
Medicine Products: